References
- Swerdlow SH, Campo E, Harris NL, . WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, IARC Press; 2008. pp 250–251, 330.
- Cazals-Hatem D, Lepaqe E, Brice P, . Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 non-mediastinal large B-cell lymphoma, a GELA (“Groupe d’Etude des Lymphomes de I’Adulte”) study. Am J Surg Pathol 1996;20: 877–888.
- Moldenhauer G, Popov SW, Wotschke B, . AID expression identifies interfollicular large B cell as putative precursors of mature B-cell malignancies. Blood 2006;107:2470–2473.
- Savage KJ, Monti S, Kutok JL, . The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003;102:3871–3879.
- Colby TV, Hoppe RT, Warnke RA. Hodgkin's disease: a clinicopathologic study of 659 cases. Cancer 1982;49:1848–1858.
- Pileri SA, Gaidano G, Zinzani PL, . Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol 2003;162:243–253.
- Rosenwald A, Wright G, Leroy K, . Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003;6:851–862.
- The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int 2000; 50:696–702.
- Steidl C, Gascoyne RD. The molecular pathogenesis of primary mediastinal large B-cell lymphoma. Blood 2011;118:2659–2669.
- Green MR, Monti S, Rodig SJ, . Integrative analysis reveals selective 9q24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 2011;116: 3268–3277.
- Hans CP, Weisenburger DD, Greiner TC, . Conformation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103: 275–282.
- Choi WW, Weisenburger DD, Greiner TC, . A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 2009;15:5494–5502.
- A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987–994.
- Carbone PP, Kaplan HS, Musshoff K, . Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971;31: 1860–1861.
- Foss HD, Reusch R, Demel G, . Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood 1999;94:3108–3113.
- Higgins JP, Warnke RA. CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol 1999;112:241–247.
- Savage KJ, Monti S, Kutok JL, . The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003;102:3871–3879.
- Gruss HJ, Boiani N, Williams DE, . Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 1994;83:2045–2056.
- Yamamoto R, Nishikori M, Kitawaki T, . PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 2008;111:3220–3224.
- Johnson NA, Boyle M, Bashashati A, . Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival. Blood 2009;113:3773–3780.